← SynDRA
LX-7101
SynDRA canonical compound SYN0038120 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | LIMK2 | ROCK1 | ROCK2 |
|---|
| Mechanism of action | LIM kinase inhibitor | rho associated kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- LIM kinase inhibitor
- rho associated kinase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AKT1
- LIMK1
- PRKACA
- HDAC6
- PRKX
- RPS6KB1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- COMT
- GAMT
- GNMT
- HNMT
- KSYK
- NNMT
- NSD2
- PNMT
- PRKACB
- PRKACG
- SYK
Cross-references
Synonyms
- LX7101
- RefChem:154458
- HY-12659
- PWPNYABQEOGNNC-UHFFFAOYSA-N
- UNII-74B3C4ZT96
- orb1707047
- SCHEMBL2713449
- LX7101 (HCl)
- SCHEMBL29375839
- SCHEMBL30596532
- GLXC-25445
- EX-A2288
- SXB18969
- BDBM50044004
- AKOS030526303
- CS-5103
- SB18903
- NCGC00484080-01
- MS-28198
- T15798
- BRD-K21038058-001-01-9
- GLXC-25446
- T32985
- LX7101 (hydrochloride)
- LX-7101 HCl
- orb2282959
- C23H30ClN7O3
- LX7101 hydrochloride
- orb1985803
- AKOS028113331
- USD88248
- MFCD23381257
- S5G8WJ39X9
- UNII-S5G8WJ39X9
- LX7101 (monohydrochloride)
- HY-12659B
- LX-7101 hydrochloride
- T85304
- SCHEMBL2714325
Look up LX-7101 in the interactive SynDRA portal →